Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Portfolio Pulse from Lekha Gupta
Several mid-cap stocks experienced significant gains last week, with Agios Pharmaceuticals, Verint Systems, and Novavax among the top performers. Agios Pharmaceuticals surged 29.13% after positive study results, Verint Systems rose 22.40% following strong Q1 financial results, and Novavax gained 21.54% after an FDA advisory committee recommended updated COVID-19 vaccines.
June 09, 2024 | 6:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Agios Pharmaceuticals shares soared 29.13% after reporting positive results from its transfusion-dependent alpha- or beta-thalassemia study, leading to several analysts raising their forecasts.
The positive study results and subsequent analyst upgrades are likely to drive short-term price appreciation for Agios Pharmaceuticals.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Halozyme Therapeutics stock grew 14.03% after the company raised its FY24 guidance.
The raised FY24 guidance is a positive indicator for Halozyme Therapeutics, likely boosting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Liberty Global shares upped 12.48% last week.
Liberty Global's notable price increase indicates positive market sentiment, likely resulting in short-term gains.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Legend Biotech shares rose 13.93% last week.
Legend Biotech's significant price increase suggests positive market sentiment, likely leading to short-term gains.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Neogen Corporation shares increased 19.25% last week.
Neogen's notable price increase indicates positive market sentiment, likely resulting in short-term gains.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Nuvalent shares rose 20.52% last week.
Nuvalent's significant price increase suggests positive market sentiment, likely leading to short-term gains.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 50
POSITIVE IMPACT
Novavax shares gained 21.54% after the FDA's advisory committee recommended updated vaccines for the JN.1-lineage of COVID-19.
The FDA advisory committee's recommendation for updated COVID-19 vaccines is a positive development for Novavax, likely boosting its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Smartsheet shares escalated 18.01% after reporting better-than-expected Q1 financial results and announcing a $150 million share repurchase program.
The strong financial performance and the announcement of a share repurchase program are likely to positively impact Smartsheet's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Twist Bioscience shares jumped 18.40% after Guggenheim initiated coverage with a Buy rating and a price target of $53.
The initiation of coverage with a Buy rating and a high price target by Guggenheim is likely to drive short-term price appreciation for Twist Bioscience.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Verint Systems shares rose 22.40% after reporting better-than-expected Q1 financial results and issuing strong FY25 guidance.
The strong financial performance and optimistic future guidance are likely to positively impact Verint Systems' stock price in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100